Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 1.25 -0.12 (-8.87%)
As of 06/12/2025 05:47 AM Eastern

VRCI vs. YGEN, ABDX, PRM, GDR, GENI, DMTR, LLAI, LLA, IDHC, and DXRX

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs. Its Competitors

Verici Dx (LON:VRCI) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment.

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Verici Dx-110.99% -71.67% -26.14%
Yourgene Health -27.55%-27.06%-6.71%

51.9% of Verici Dx shares are owned by institutional investors. Comparatively, 23.3% of Yourgene Health shares are owned by institutional investors. 17.1% of Verici Dx shares are owned by insiders. Comparatively, 64.4% of Yourgene Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Verici Dx has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Verici Dx has higher earnings, but lower revenue than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verici Dx£5.91M0.64-£6.56M-£1.73-0.73
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A

In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company Overall Sentiment
Verici Dx Neutral
Yourgene Health Neutral

Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.

CompanyUnderperformOutperform
Verici DxN/AN/A
Yourgene HealthOutperform Votes
17
53.13%
Underperform Votes
15
46.88%

Summary

Yourgene Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£3.80M£731.82M£5.61B£2.93B
Dividend YieldN/A5.44%5.28%4.90%
P/E Ratio-0.732.0927.14125.70
Price / Sales0.64480.02411.84243,028.65
Price / Cash1.3111.4238.2528.07
Price / Book0.282.877.064.71
Net Income-£6.56M£308.37B£3.23B£5.91B
7 Day Performance-16.47%0.22%0.80%12.66%
1 Month Performance0.24%5.02%9.71%16.37%
1 Year Performance-81.46%-8.71%32.12%78.39%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 1.25
-8.9%
N/A-82.1%£3.80M£5.91M-0.7319Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 7.50
+7.1%
N/A-39.5%£14.52M£3.84M-18.2484Gap Down
PRM
Proteome Sciences
N/AGBX 2.90
-11.0%
N/A-16.0%£8.56M£10.88B-2.10240Gap Down
GDR
genedrive
N/AGBX 1.47
+5.0%
N/A-10.0%£8.35M£1.50M-0.4143Gap Down
High Trading Volume
GENI
GENinCode
N/AGBX 2.28
-4.2%
N/A-66.5%£4.05M£2.67M-0.662,300Gap Down
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-79.4%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
flat
N/A+0.6%£10.60B£23.29T13.386,692
DXRX
Diaceutics
2.5948 of 5 stars
GBX 130
-2.3%
GBX 160
+23.1%
-1.2%£109.71M£26.08M-38.56151

Related Companies and Tools


This page (LON:VRCI) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners